Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Design: Abnormalities in glucose homeostasis have been described in patients with primary aldosteronism (PA) but most studies show inconsistent results. Therefore, we aimed to compare the prevalence of type 2 diabetes mellitus and metabolic syndrome (MetS) in newly diagnosed PA patients to a matched control cohort of the background population. Methods: In total, 305 PA patients of the prospective German Conn's Registry were compared to the population-based Study of Health In Pomerania (SHIP1;n=2454). A 1:1 match regarding sex, age, and BMI resulted in 269 matched pairs regarding type 2 diabetes and 183 matched pairs regarding MetS. Of the total, 153 PA patients underwent oral glucose tolerance testing (OGTT) at diagnosis and 38 PA patients were reevaluated at follow-up. Results: Type 2 diabetes and MetS were significantly more frequent in PA patients than in the control population (17.2% vs 10.4%,P=0.03; 56.8% vs 44.8%,P=0.02 respectively). Also, HbA1c levels were higher in PA patients than in controls (P<0.01). Of the total, 35.3% of non-diabetic PA patients showed an abnormal OGTT (¼ newly diagnosed type 2 diabetes and ¾ impaired glucose tolerance). PA patients with an abnormal OGTT at baseline presented with significantly improved 2 h OGTT glucose (P=0.01) at follow-up. We detected a negative correlation between 2 h OGTT glucose levels and serum potassium (P<0.01). Conclusions: Type 2 diabetes and MetS are more prevalent in patients with PA than in controls matched for sex, age, BMI, and blood pressure. This may explain in part the increased cardiovascular disease morbidity and mortality in PA patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism is also associated with glucose intolerance and an increased risk of type 2 diabetes (2–4)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [4]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2012) · Diabetes Care · doi:10.2337/dc12-s064 · Cited by 1,491
Cohort Profile: The Study of Health in Pomerania
Volzke, H., Alte, D., Schmidt, C. O., Radke, D., Lorbeer, R., Friedrich, N., Aumann, N., Lau, K., Piontek, M., Born, G., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyp394 · Cited by 1,000
Self-citationJohn, U., Hensel, E., L�demann, J., Piek, M., Sauer, S., Adam, C., Born, G., Alte, D., Greiser, E., Haertel, U., et al. (2001) · Sozial- und Pr�ventivmedizin SPM · doi:10.1007/bf01324255 · Cited by 549
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Brown, N. J. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.110 · Cited by 451
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Hannemann, A., & Wallaschofski, H. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1295438 · Cited by 340
Self-citationRenin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance
Cooper, S. A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., & Sowers, J. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00522.2007 · Cited by 317
Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro
Howell, S. L., & Taylor, K. W. (1968) · Biochemical Journal · doi:10.1042/bj1080017 · Cited by 300
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267
Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
Born-Frontsberg, E., Reincke, M., Rump, L. C., Hahner, S., Diederich, S., Lorenz, R., Allolio, B., Seufert, J., Schirpenbach, C., Beuschlein, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2116 · Cited by 261
Self-citationPrevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium
Helderman, J. H., Elahi, D., Andersen, D. K., Raizes, G. S., Tobin, J. D., Shocken, D., & Andres, R. (1983) · Diabetes · doi:10.2337/diab.32.2.106 · Cited by 252
Effect of experimental potassium deficiency on glucose and insulin metabolism
Rowe, J. W., Tobin, J. D., Rosa, R. M., & Andres, R. (1980) · Metabolism · doi:10.1016/0026-0495(80)90074-8 · Cited by 226
Diagnosis of primary aldosteronism: from screening to subtype differentiation
Mulatero, P., Dluhy, R. G., Giacchetti, G., Boscaro, M., Veglio, F., & Stewart, P. M. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.007 · Cited by 156
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
Chatterjee, R., Yeh, H.-C., Shafi, T., Selvin, E., Anderson, C. A. M., Pankow, J. S., Miller, E., & Brancati, F. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.362 · Cited by 131
Matrozova, J., Steichen, O., Amar, L., Zacharieva, S., Jeunemaitre, X., & Plouin, P.-F. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.122002 · Cited by 118
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2158-9 · Cited by 109
Škrha, J., Haas, T., Šindelka, G., Prázný, M., Widimský, J., Cibula, D., & Svačina, Š. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030024 · Cited by 108
Schipf, S., Werner, A., Tamayo, T., Holle, R., Schunk, M. V., Maier, W., Meisinger, C., Thorand, B., Berger, K., Mueller, G., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03578.x · Cited by 108
Riester, A., Fischer, E., Degenhart, C., Reiser, M. F., Bidlingmaier, M., Beuschlein, F., Reincke, M., & Quinkler, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3789 · Cited by 102
Self-citationIs Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn's Registry
Reincke, M., Meisinger, C., Holle, R., Quinkler, M., Hahner, S., Beuschlein, F., Bidlingmaier, M., Seissler, J., & Endres, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246189 · Cited by 98
Self-citationA possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94
The effect of aldosterone on glucose metabolism
Corry, D. B., & Tuck, M. L. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0065-2 · Cited by 90
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88
Self-citationAdipokines and Cardiometabolic Profile in Primary Hyperaldosteronism
Iacobellis, G., Petramala, L., Cotesta, D., Pergolini, M., Zinnamosca, L., Cianci, R., De Toma, G., Sciomer, S., & Letizia, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2204 · Cited by 80
Hao, G., Wang, Z., Guo, R., Chen, Z., Wang, X., Zhang, L., & Li, W. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-148 · Cited by 76
Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment
Šindelka, G., Widimský, J., Haas, T., Prázný, M., Hilgertová, J., & Škrha, J. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1329211 · Cited by 75
Sherajee, S. J., Fujita, Y., Rafiq, K., Nakano, D., Mori, H., Masaki, T., Hara, T., Kohno, M., Nishiyama, A., & Hitomi, H. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.240697 · Cited by 73
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68
Al-Mallah, M. H., Khawaja, O. A., Sinno, M., Alzohaili, O., & Abou‐Samra, A. (2010) · PubMed · Cited by 56
The Diagnosis and Treatment of Primary Hyperaldosteronism in Germany
Schirpenbach, C., Segmiller, F., Diederich, S., Hahner, S., Lorenz, R., Rump, L. C., Seufert, J., Quinkler, M., Bidlingmaier, M., Beuschlein, F., et al. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0305 · Cited by 54
Self-citationHannemann, A., Friedrich, N., Lüdemann, J., Völzke, H., Rettig, R., Peters, J., Reincke, M., Döring, A., Nauck, M. A., & Wallaschofski, H. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1247545 · Cited by 49
Self-citationFeedforward activation of endothelial ENaC by high sodium
Korte, S., Straeter, A. S., Drüppel, V., Oberleithner, H., Jeggle, P., Großmann, C., Fobker, M., Nofer, J., Brand, E., & Kusche‐Vihrog, K. (2014) · The FASEB Journal · doi:10.1096/fj.14-250282 · Cited by 47
Does the treatment of primary hyperaldosteronism influence glucose tolerance?
Štrauch, B., Widimsky, J., Šindelka, G., & Škrha, J. (2003) · Physiological Research · doi:10.33549/physiolres.930298 · Cited by 44
Ronconi, V., Turchi, F., Rilli, S., Di Mattia, D., Agostinelli, L., Boscaro, M., & Giacchetti, G. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.007 · Cited by 41
Jin, H. M., Zhou, D. C., Gu, H. F., Qiao, Q. Y., Fu, S. K., Liu, X. L., & Pan, Y. (2013) · Endocrinology · doi:10.1210/en.2013-1115 · Cited by 40
Analysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism
Urbanet, R., Pilon, C., Calcagno, A., Peschechera, A., Hubert, E.-L., Giacchetti, G., Gomez-Sanchez, C., Mulatero, P., Toffanin, M., Sonino, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0097 · Cited by 38
The metabolic syndrome in primary aldosteronism
Fallo, F., Federspil, G., Veglio, F., & Mulatero, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0009-y · Cited by 30
Increased insulin sensitivity in patients with aldosterone producing adenoma
Ishimori, M., Takeda, N., Okumura, S., Murai, T., Inouye, H., & Yasuda, K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02573.x · Cited by 24
Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice
Lüders, S., Hammersen, F., Kulschewski, A., Venneklaas, U., Züchner, C., Gansz, A., Schnieders, M., Pfarr, E., Sturm, C., Paar, W. D., et al. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00518.x · Cited by 23
Fischer, E., Reuschl, S., Quinkler, M. O., Rump, L. C., Hahner, S., Bidlingmaier, M., Reincke, M., & For the Participants of the German Conn's Registry - Else Kröner-Fresenius-Hyperaldosteronism Registry (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1343448 · Cited by 23
Self-citationOvert Diabetes Mellitus in a Patient with Combined Primary Aldosteronism and Cushing's Syndrome
Sasaki, N., Iwase, M., Arima, H., Nohara, S., Bandai, S., Yao, T., Fujii, K., & Iida, M. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1855 · Cited by 10
Cited by
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Vaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 299
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
“4) (n = 54) 152 (20) (n = 54) 95 (13) (n = 54) 71/71 100% 71/71 100%”
Self-citationPrevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies
Ansarimoghaddam, A., Adineh, H. A., Zareban, I., Iranpour, S., HosseinZadeh, A., & Kh, F. (2018) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2017.11.004 · Cited by 239
Metadata
- Authors
- Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., Beuschlein, F., Quinkler, M., Hannemann, A., & _, _.
- Affiliations
- Universitätsmedizin Greifswald (DE)
- Corresponding author
- Quinkler, Marcus
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11
- Volume
- 173
- Issue
- 5
- Pages
- 665-675
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2152681812
- Semantic Scholar
- ee60be55335b1c9d8f8d38fcd59bf5bfa032d730
- Cited by
- 155
- References
- 51
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 22 · 2023: 19 · 2022: 18 · 2021: 12 · 2020: 15 · 2019: 14 · 2018: 17 · 2017: 9 · 2016: 6 · 2015: 2
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- primary aldosteronism, type 2 diabetes, metabolic syndrome, glucose homeostasis, impaired glucose tolerance, HbA1c, serum potassium, cardiovascular risk
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Germany, Humans, Hyperaldosteronism, Male, Middle Aged, Prospective Studies, Registries, Comorbidity, Prevalence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.